Zero Hedge

Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance

Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance

Novo Nordisk shares jumped as much as 9% in Copenhagen, suggesting the stock may finally be bottoming out after a vicious multi-year bear market. The move followed the Danish drugmaker's decision to raise its 2026 guidance ranges for adjusted sales and adjusted operating profit, citing solid momentum in Wegovy sales.

Novo now expects full-year sales and profit declines of around 12%, down from a previous forecast of around 13%. The upgraded outlook was "driven by increased expectations for GLP-1 product sales," according to the company.

Here's a snapshot of the new full-year forecast, courtesy of Bloomberg:

  • Sees adjusted change in sales at constant exchange rates -4% to -12%, saw -5% to -13%, estimate -7.63% (Bloomberg Consensus)

  • Sees adjusted change in operating profit at constant FX -4% to -12%, saw -5% to -13%, estimate -8.26%

The key bright spot was momentum in the Wegovy pill:

  • Wegovy pill was launched in the US on 5 January 2026, and for the week ending 17 April, total weekly prescriptions exceeded 200,000. Coupled with total prescriptions for Q1 2026 of around 1.3 million and now more than 2 million since launch, it marks the strongest-ever GLP-1 volume launch in the US. Q1 2026 sales for the Wegovy pill reached DKK 2,256 million, impacted by pre-launch pipeline fill with wholesalers and telehealth partners.

  • Pending regulatory decisions, the first Wegovy pill launches outside the US are expected during the second half of 2026.

"We have seen more than 1 million people using the Wegovy pill," CEO Mike Doustdar told analysts on an earnings call earlier. He noted that patients are switching from competing products, with "limited cannibalization" of Novo's other drugs.

Still, Novo's overall business remains under pressure. First-quarter sales fell 10% to 70.1 billion Danish kroner, while adjusted operating profit dropped 15%. Diabetes drug sales fell 18%, with Ozempic hitting its lowest level in two years.

Novo is trying to regain momentum after losing market share to Eli Lilly's Zepbound injection.

Novo shares in Copenhagen jumped as much as 9%. Shares have been locked in a vicious, nearly two-year bear market, down 70% from their peak.

Analyst commentary, courtesy of Bloomberg:

Barclays (equal weight)

  • Oral Wegovy was "off to a strong start," analyst James Gordon writes in a note.

  • Sees questions on supply capacity when the pill launches in other countries, expected in 2H

  • Sees FY consensus expectations being increased by low single- digits

BMO Capital Markets (market perform)

  • The Wegovy pill "makes a splash" in its debut, analyst Evan Seigerman writes in a note.

  • It's encouraging that roughly 15%-16% of pill patients are filling scripts for the highest dosages.

  • This "could be a leading indicator for improved revenue going forward, given their higher price."

  • Wegovy and Ozempic injectables also beat expectations, "showing more resilience in the face of competition within class"

Jefferies (hold)

  • Although the 2026 guidance was nudged higher, it still leaves consensus expectations at the upper end of the range, analyst Michael Leuchten writes in a note.

  • The change in guidance probably won't have a positive impact on consensus estimates.

  • It could actually drag pretax profit and EPS expectations down a couple of percent.

Intron Health (sell)

  • Sales beat expectations by 1%, driven by Wegovy pill stocking of ~$125m, analyst Naresh Chouhan writes in a note

  • Meanwhile, gross margin was 30 bps worse than expected

Morgan Stanley (equal weight)

  • 1Q sales were a "small" beat, driven by the Wegovy pill — helped by stocking — and international operations, analyst Thibault Boutherin writes in a note

  • Lower operating costs helped the adjusted EBIT beat

  • Still sees the bottom end of the guidance as "conservative" and expects the company to finish the year "in the upper half of the guidance."

Did Novo finally bottom?

Tyler Durden Wed, 05/06/2026 - 06:55

There Needs To Be A Stronger European Element In NATO, Says Starmer

There Needs To Be A Stronger European Element In NATO, Says Starmer

Authored by Victoria Friedman via The Epoch Times (emphasis ours),

British Prime Minister Sir Keir Starmer said on May 4 that there needs to be a stronger European element in NATO, as the United States reconsiders its relationship with the defense alliance and pivots toward other security priorities domestically and globally.

British Prime Minister Keir Starmer at the Elysee Palace in Paris on Jan 6, 2026. Ludovic Marin/AP

Starmer acknowledged during a panel discussion at the European Political Community summit in Yerevan, Armenia, that, in terms of defense and security, Europe has “got behind over many years, now.”

We’re not where we need to be,” he said.

The British prime minister alluded to the impact of the Ukraine–Russia war and, more recently, the Iran conflict on global security and economic stability, saying that Europe, especially, had to come together around these issues.

“There needs to be a stronger European element in NATO. I have no doubt about that,” he said.

Starmer said that while there needed to be a stronger European element in defense and security, “we’ve been behind the curve for too long: over dependencies, over reliance, and assumptions about the world that we live in—they’ve gone.”

“We now need to lead out of this, and we need to do it at pace because these impacts are real,” Starmer said.

“The alliances that are under tension are real, and how we, as a group of leaders, respond now will likely define what goes on for many years—arguably for a generation.”

US Reorients Defense Priorities

U.S. President Donald Trump has long maintained that Europe should rely less on the United States for its security and that European NATO allies should increase their defense spending. This approach was formally accepted by NATO when, in June 2025, allies agreed to raise defense spending targets from 2 percent of gross domestic product to 5 percent by 2035.

The United States has also reoriented its defense and security priorities.

The Pentagon on Jan. 23 released its National Defense Strategy, which outlines the U.S. plan to prioritize homeland defense, including by “defending America’s interests throughout the Western Hemisphere,” according to the document.

It also said the United States would encourage partners in other parts of the world, including Europe, to take primary responsibility for their own defense “with critical but limited support from U.S. forces.”

Tension Over Support in Iran Conflict

In recent weeks, Trump has expressed frustration with the lack of support from NATO allies during the Iran war, prompting him to consider pulling out of the alliance.

Trump told British newspaper The Telegraph in an interview published on April 1 that his request for assistance in the Strait of Hormuz was a test that allies did not pass.

The president’s remarks followed similar comments from Secretary of State Marco Rubio.

Rubio said on March 30 that one of the benefits of U.S. membership in the alliance is that it gives Washington access to station troops, aircraft, and arms in other parts of the world—including much of Europe.

However, during Operation Epic Fury, “we have countries like Spain, a NATO member that we are pledged to defend, denying us the use of their airspace and bragging about it, denying us the use of our—of their bases,” Rubio said, adding that “there are other countries that have done that as well.”

Rubio said that while he supported NATO, his backing of the alliance was based on the assumption that there are reciprocal arrangements.

“But if NATO is just about us defending Europe if they’re attacked, but then denying us basing rights when we need them, that’s not a very good arrangement,” he said.

NATO Secretary-General Mark Rutte delivers a speech at Aselsan Defence company as part of his official visit to Turkey, in Ankara on April 22, 2026. Adem Altan/AFP via Getty Images

This week, NATO Secretary-General Mark Rutte said that NATO members had received Trump’s message about agreements allowing the United States to access European bases.

Yes, ​there has been some disappointment from the U.S. side, but Europeans have listened,” Rutte told reporters at the same European Political Community summit in ​Armenia on May 4.

“They are now making sure that all the bilateral ​basing agreements are being implemented.”

Tyler Durden Wed, 05/06/2026 - 06:30

Carbon Neutral, Speech Negative: Amsterdam Bans Ads Featuring Meat & Fossil Fuels

Carbon Neutral, Speech Negative: Amsterdam Bans Ads Featuring Meat & Fossil Fuels

Authored by Jonathan Turley,

In The Indispensable Right: Free Speech in an Age of Rage,” I write about how censorship often becomes an insatiable appetite once countries go down the road of speech regulation. There is no better example than the Dutch and their recent ban on public ads for meat and fossil fuels. Activists have imposed similar limitations on advertising for products in the United States, from alcohol to tobacco. However, the Dutch law reflects how this tendency can metastasize into shielding citizens from unhealthy choices or influences.

It appears that Dutch painters such as Pieter Aertsen (with his work A Meat Stall with the Holy Family Giving Alms, above) were promoting harmful imagery in their work. As for Rembrandt’s “Slaughtered Ox,” the Dutch master is now little more than a climate change denier.

Starting on May 1, the ban on such images became part of Amsterdam’s push to achieve carbon neutrality by 2050. While purportedly neutral on carbon, it is manifestly negative on free speech.

As with other anti-free speech measures in Europe, this push again came from the left. The GreenLeft Party’s Anneke Veenhoff explained “I mean, if you want to be leading in climate policies and you rent out your walls to exactly the opposite, then what are you doing?”

The answer is engaging in free speech.

This is, of course, commercial speech, which is often subject to a lower level of protection. However, this shows the danger of using the differential standard to target products or industries viewed as unhealthy or ill-advised for consumers.

In Amsterdam, the ban will cover industries such as airlines, including KLM Royal Dutch Airlines, one of the largest employers and revenue generators in the country.

Notably, activists compare this to cigarette advertising bans, confirming the very slippery slope danger that those companies raised when they were targeted.

Hannah Prins, a paralegal at Advocates for the Future, is quoted as saying, “I don’t think it’s normal to see murdered animals on billboards. So I think it’s very good that that’s going to change.”

Other Dutch cities are now following suit, including Haarlem, Utrecht, and Nijmegen.

Of course, prostitutes still advertise live in Amsterdam and marijuana is a major industry for tourists.

If you want drugs, there are ample choices.

However, if you want a steak, you will have to rely on word-of-mouth directions.

Tyler Durden Wed, 05/06/2026 - 05:00

Pages